Product Center
-
World Influenza Conference 2024 | Decoding New Possibilities for the Future of Influenza Vaccines
2024-07-09From July 5 to 7, the 2024 World Influenza Conference, co-sponsored by the Chinese Preventive Medicine Association, the Asia-Pacific Influenza Control Alliance, the Chinese Center for Disease Control and Prevention, and the Chinese Academy of Medical Sciences, was held in Hainan, China.
Read More -
2024 National Vaccine and Health Conference
2024-04-22On April 20-21, the 2024 National Vaccine and Health Conference was held in Xiongan New Area, Hebei Province. Ab&B Bio brought its first product, the quadrivalent influenza virus subunit vaccine (Huierkangxin®, HRK-X®), to the event once again.
Read More -
Further Advances in Orthopoxvirus mRNA Vaccines
2024-04-12From April 2 to April 4, 2024, Dr. Xiong Nolin, Deputy General Manager of Yither Biotech (Shanghai) Co., Ltd., a wholly-owned subsidiary of Ab&B Bio-Tech Co., Ltd. (JS), was invited to participate in the World Vaccine Congress 2024, where he delivered a keynote speech and presented the results of the company's important R&D project on the Orthopoxvirus mRNA vaccine, which attracted great interest and recognition from international counterparts.
Read More -
Zhang Xiaobing, a member of the Standing Committee of the Taizhou Municipal Party Committee and Secretary of the Party Working Committee of the Pharmaceutical High-tech Zone, visited the company for an investigation.
2019-01-14Zhang Xiaobing, a member of the Standing Committee of the Taizhou Municipal Party Committee and Secretary of the Party Working Committee of the Pharmaceutical High-tech Zone, visited the company for an investigation.
Read More
Got a project? Contact us today !
At Ab&B Bio, our mission is to care for life and protect health by developing globally innovative vaccines.
Contact
E-mail:haixin.zhang@yitherbiotech.com
Add:No. 32, Xinglin Road, Medical High-tech Zone, Taizhou City
Quick view
Follow us
